Genetics, haloperidol, and the Fos response in the basal ganglia: A comparison of the C57BL/6J and DBA/2J inbred mouse strains

Neuropsychopharmacology

Volumn 18, Issue 6, 1998, Pages 480-491

  Patel, Nilay ^a   Hitzemann, Barbara ^a   Hitzemann, Robert ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basal ganglia; C Fos; Catalepsy; Genetics; Haloperidol; Inbred strains; Mouse

Indexed keywords

HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CATALEPSY; CAUDATE NUCLEUS; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; HALOPERIDOL; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PROTO-ONCOGENE PROTEINS C-FOS; SPECIES SPECIFICITY;

EID: 0031919295     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00196-6     Document Type: Article

References (39)

1. Carelli RM, West MO Representation of the body by single neurons in the dorsolateral straitum of the awake, unrestrained rat. J Comp Neurol. 309:1991;231-249.
2. Cipp L (1995): Genetics, dopamine and behavior. M.S. Thesis. Stony Brook, NY, Dept. of Molecular and Cellular Pharmacology, SUNY Stony Brook.
3. Dains K, Hitzemann B, Hitzemann R Genetics, neuroleptic-response and the organization of cholinergic neurons in the mouse striatum. J Pharmacol Exp Therap. 279:1996;1430-1438.
4. Deutch AY, Cameron DS Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
5. Deutch AY, Lewis DA, Whitehead RE, Elsworth JD, Iadarola MJ, Redmond DE, Roth RH Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse. 23:1996;182-191.
6. Dilts RP, Helton TE, McGinty JE Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse. 13:1993;251-263.
7. Dragunow M, Robertson GS, Faull LM, Robertson HA, Jansen K D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
8. Erwin VG, Womer DE, Campbell AD, Jones BC Pharmacogenetics of cocaine. II. Mesocorticolimbic and striatal dopamine receptors in C57BL and DBA mice Pharmacogenetics. 3(4):1993;189-196.
9. Franza BR, Sambucetti LC, Cohen DR, Curran T Analysis of fos protein complexes and fos-related antigens by high resolution two-dimensional gel electrophoresis. Oncogene. 1:1987;213-221.
10. Franza BR, Rauscher FJ, Josephs SF, Curran T The fos complex and fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science. 239:1988;1150-1153.
11. Gerfen CR, Engber TM, Maha LC, Susel Z, Chase TN, Monsma FJ, Sibley DR D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
12. Guo N, Robertson GS, Fibiger HC Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588:1992;164-167.
13. Heimer L, Zahm DS, Alheid GF Basal Ganglia. Paxinos G The Rat Nervous System. 2:1995;579-628 Academic Press, San Diego.
14. Hitzemann RJ, Dains K, Bier-Langing CM, Zahniser NR On the selection of mice for haloperidol response and non-response. Psychopharmacology. 103:1991;244-250.
15. Hitzemann R, Qian Y, Hitzemann B Dopamine and acetylcholine cell density in the neuroleptic responsive (NR/Ibg) and neuroleptic non-responsive (NNR/Ibg) lines of mice. J Pharmacol Exp Ther. 266:1993;431-438.
16. Hitzemann B, Dains K, Kanes S, Hitzemann R Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. J Pharmacol Exp Ther. 271:1994;969-976.
17. Hitzemann R, Qian Y, Kanes S, Dains K, Hitzemann B Genetics and the organization of the basal ganglia. Int Rev Neurobiol. 38:1995;43-94.
18. Ishibashi T, Ikeda K, Ishida K, Yasui J, Tojima R, Nakamura M, Ohno Y Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum. Eur J Pharmacol. 303:1996;247-251.
19. 2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J Pharmacol Exp Ther. 267:1993;538-547.
20. Kanes S, Dains K, Cipp L, Gatley J, Hitzemann B, Rasmussen E, Sanderson S, Silverman M, Hitzemann R Mapping the genes for haloperidol-induced catalepsy. J Pharmacol Exp Therap. 277:1996;1016-1025.
21. Kinon BJ, Kane JM Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behaviorally hypersensitivity which subsequently develops. Psychopharmacology. 98:1989;465-471.
22. Kodsi MH, Swerdlow NR Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behavioral Neurosci. 109:1995;912-928.
23. McCaughran J Jr., Mahjubi E, Decena E, Hitzemann R Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition. Psychopharmacology. 134:1997;131-139.
24. Merchant KM, Dorsa DM Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci USA. 90:1993;3447-3451.
25. Miller JC Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem. 54:1990;1453-1455.
26. Nguyen TV, Kasofsky B, Birnbaum R, Cohen BM, Hyman SE Differential expression of Fos and Zif 268 in rat striatum following haloperidol, clozapine and amphetamine. Proc Natl Acad Sci USA. 89:1992;4270-4274.
27. Pisa M Motor functions of the striatum in the rat. critical role of the lateral region in tongue and forelimb reaching Neuroscience. 24:1988;453-463.
28. 2 dopamine receptor distribution in the neuroleptic non-responsive (NNR) and neuroleptic responsive (NR) lines of mice -a quantitative receptor autoradiographic study. J Pharmacol Exp Ther. 261:1992;341-348.
29. 2 mRNA levels in the neuroleptic-responsive (NR) and neuroleptic non-responsive (NNR) lines of mice. J Pharmacol Exp Ther. 267:1993;1582-1590.
30. Rasmussen E, Cipp L, Hitzemann R (1997): Haloperidol-induced catalepsy maps to the piebald (s) but not the albino(c) locus in a CXLP cross. Behav Gen, in press.
31. Robertson GS, Fibiger HC Neuroleptics increase c-Fos expression in the forebrain. contrasting effects of haloperidol and clozapine Neuroscience. 46:1992;315-328.
32. Robertson GS, Matsumura H, Fibiger HC Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Therap. 271:1994;1058-1066.
33. Robertson GS, Fibiger HC Effects of olanzapine on regional c-Fos expression in rat forebrain. Neuropsychopharmacology. 14:1996;105-110.
34. Ruskin DN, Marshall JF D1 receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Research. 703:1995;156-164.
35. Ruskin DN, Marshall JF The dopaminergic induction Fos immunoreactivity in identified populations of globus pallidus neurons. 1996;Washington, Soc Neuroscience Abstract #797.5. DC.
36. Seeman P, Van Tol HHM Dopamine receptor pharmacology. TIPS. 15:1994;264-270.
37. Sonnenberg JL, Mitchelmore C, MacGregor-Leon PF, Hempstead J, Morgan JI, Curran T Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in mammalian brain. J Neurosci Res. 24:1989;72-80.
38. Swerdlow NR, Braff DL, Taaid N, Geyer MA Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psych. 51:1994;139-154.
39. Wirtshafter D, Asin KE Dopamine antagonists induce fos like immunoreactivity in the substantia nigra and entopeduncular nucleus. Brain Res. 670:1995;205-214.